102 related articles for article (PubMed ID: 18700069)
1. Uropharmacology for the primary care physician.
Gittens PR; Lallas CD; Pe ML; Perkel R; Folia C; Gomella LG
Can J Urol; 2008 Aug; 15 Suppl 1():78-91; discussion 91. PubMed ID: 18700069
[TBL] [Abstract][Full Text] [Related]
2. Uropharmacology in primary care: 2010 update.
Gomella LG; Lallas CD; Perkel R; Folia C; Hirsch I; Das A; Shenot P
Can J Urol; 2010 Feb; 17 Suppl 1():35-51. PubMed ID: 20170599
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology for common urologic diseases: 2011 review for the primary care physician.
Liu XS; Folia C; Gomella LG
Can J Urol; 2011 Apr; 18 Suppl():24-38. PubMed ID: 21501548
[TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy for the primary care physician.
Casey RW; Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
[TBL] [Abstract][Full Text] [Related]
5. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
Hollingsworth JM; Hollenbeck BK; Daignault S; Kim SP; Wei JT
J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
[TBL] [Abstract][Full Text] [Related]
6. Emerging therapies: what's new is old and what's old is new.
Barkin J; Folia C
Can J Urol; 2012 Oct; 19 Suppl 1():49-53. PubMed ID: 23089348
[TBL] [Abstract][Full Text] [Related]
7. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
[TBL] [Abstract][Full Text] [Related]
8. Effects of obesity and weight loss in patients with nononcological urological disease.
Natarajan V; Master V; Ogan K
J Urol; 2009 Jun; 181(6):2424-9. PubMed ID: 19371912
[TBL] [Abstract][Full Text] [Related]
9. Validated questionnaires for assessing sexual dysfunction and BPH/LUTS: solidifying the common pathophysiologic link.
Rosen RC; Seftel AD
Int J Impot Res; 2008 Dec; 20 Suppl 3():S27-32. PubMed ID: 19002122
[TBL] [Abstract][Full Text] [Related]
10. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
12. Urological implications of cyclophosphamide and ifosfamide.
Lawson M; Vasilaras A; De Vries A; Mactaggart P; Nicol D
Scand J Urol Nephrol; 2008; 42(4):309-17. PubMed ID: 18781541
[TBL] [Abstract][Full Text] [Related]
13. [Urology].
Chollet Y; Aymon D; Cardinaux C; Praz V; Tawadros T; Treuthardt C; Vaucher L; Wisard M; Zaman K; Zarkik Y; Jichlinski P
Rev Med Suisse; 2007 Jan; 3(94):168-71. PubMed ID: 17354544
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for Helicobacter pylori infection in urological diseases?
Al-Marhoon MS
Urol J; 2008; 5(3):139-43. PubMed ID: 18825618
[TBL] [Abstract][Full Text] [Related]
15. Testosterone and the primary care physician.
Tomlinson JM
Int J Clin Pract; 2007 Apr; 61(4):538-9. PubMed ID: 17394425
[No Abstract] [Full Text] [Related]
16. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.
Karazindiyanoğlu S; Cayan S
Aging Male; 2008 Sep; 11(3):146-9. PubMed ID: 18821291
[TBL] [Abstract][Full Text] [Related]
17. Current management of overactive bladder.
Cartwright R; Renganathan A; Cardozo L
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):489-95. PubMed ID: 18797274
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.
Klotz L; Boccon-Gibod L; Shore ND; Andreou C; Persson BE; Cantor P; Jensen JK; Olesen TK; Schröder FH
BJU Int; 2008 Dec; 102(11):1531-8. PubMed ID: 19035858
[TBL] [Abstract][Full Text] [Related]
19. Role of oral medications in spasticity management.
Watanabe TK
PM R; 2009 Sep; 1(9):839-41. PubMed ID: 19769918
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of overactive bladder in men.
Blaivas JG; Marks BK; Weiss JP; Panagopoulos G; Somaroo C
J Urol; 2009 Dec; 182(6):2814-7. PubMed ID: 19837417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
